ACTIVE SUBSTANCE / INN

LUMASIRAN SODIUM

Brand name(s): OXLUMO
FDA LISTED
PRESCRIPTION
NDA214103
ACTIVE SUBSTANCE
Lumasiran Sodium
REGULATORS
FDA
SPONSORS / MAH
ALNYLAM PHARMS INC
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
OXLUMONDA214103ALNYLAM PHARMS INCPrescription

FULL INTELLIGENCE ON LUMASIRAN SODIUM

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →